The Fracture Risk assessment tool (FRAX) is used to assess the need for prescription drug therapy in patients with low bone density. Which of the following statements apply to this tool?
A. The tool predicts the risk of osteoporosis-related fracture in th
A
JV is a 60 year old post-menopausal female who is overweight and sedentary. Last year, while taking a five hour cross-country flight, she developed a deep vein thrombosis ( DVY)/ This was her second DVT in two years. She has refused warfarin, but agreed t
A
Select the correct statement concerning Brisdelle:
A. It cannot be used with tamoxifen
B. It can cause hypernatremia
C. It contains sertraline
D. It can be used safely with warfarin
E. It is indicated for depression associated with menopause
A
The DEA has placed topical testosterone products into this scheduled category:
A. CIII
B. CV
C. CII
D. CIV
E. CI
A
A patient will be counseled on the AndroGel pump. He is using it for the first time. Which of the following are correct counseling statements? (Select ALL that apply.)
A. Do not let pregnant women touch the site of application of go near the medicine pump
A, B, E
Which of the following treatments for osteoporosis causes hypercalcemia?
A. Ibandronate
B. Risedronate
C. Calcitonin
D. Teriparatide
E. Denosumab
D
A prescriber is asking for information about the Reclast injection. Choose the correct statement:
A. The primary use of Reclast is in patients who cannot tolerate an oral bisphosphonate
B. The most common side effect of Reclast is esophagitis
C. Reclast c
A
Which of the following natural products can be used to help vasomotor symptoms (Select ALL that apply.)
A. Saw palmetto
B. Red clover
C. Evening Primrose Oil
D. Soy
E. Black cohosh
B, C, D, E
Which of the following statements concerning denosumab are correct?
A. it comes in an injectable and oral formulation
B. Denosumab is administered every six months, in a medical office
C. It is used for hypercalcemia of malignancy in the formulation calle
B